Hybrid Nanomaterials for Drug Delivery covers a broad range of hybrid nanomaterials and nanocomposites used in drug delivery systems. The book reviews a variety of hybrid nanomaterials and structures, including polymer-lipid, chitosan-based, protein-inorganic, quantum dot hybrids, and more. The strengths, limitations and regulatory aspects of hybrid drug delivery systems are also discussed, allowing readers to make informed decisions when choosing to utilize hybrid nanomaterials. Users will find this to be an exciting and comprehensive look into this emerging area. It will be of particular…mehr
Hybrid Nanomaterials for Drug Delivery covers a broad range of hybrid nanomaterials and nanocomposites used in drug delivery systems. The book reviews a variety of hybrid nanomaterials and structures, including polymer-lipid, chitosan-based, protein-inorganic, quantum dot hybrids, and more. The strengths, limitations and regulatory aspects of hybrid drug delivery systems are also discussed, allowing readers to make informed decisions when choosing to utilize hybrid nanomaterials. Users will find this to be an exciting and comprehensive look into this emerging area. It will be of particular interest to academics and researchers working in materials science, engineering, biomedical engineering, nanotechnology and pharmaceutical science.
Multi nanocarrier-based hybrid systems are an emerging concept in the field of drug delivery that allow researchers to avoid some of the challenges faced when administering drugs, such as low bioavailability, development of drug resistance, toxicities, premature drug release, and therapeutic efficacy.
Dr. Prashant Kesharwani is an assistant professor of pharmaceutics at School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India. He has more than 12 years of teaching, research, and industrial experience at international levels from various countries, including the United States, Malaysia, and India. An overarching goal of his current research is the development of nanoengineered drug delivery systems for various diseases. He has more than 300 international publications in well-reputed journals and more than 25 international books (Elsevier). He is a recipient of many research grants from various funding bodies. He is also the recipient of several internationally acclaimed awards, such as "USERN Laureate award?, most prestigious "Ramanujan Fellowship Award?. He actively participates in outreach and scientific dissemination for the service of the wider community.
Inhaltsangabe
1. Nanostructures and their associated challenges for drug delivery 2. Characterization techniques of hybrid drug delivery systems 3. Hybrid drug nanocrystals for drug delivery 4. Hybrid nanogel systems for drug delivery 5. Polymer-lipid hybrid nanostructures for drug delivery 6. Hybrid chitosan-based drug delivery systems for drug delivery 7. Hybrid polymer-metal composites for drug delivery 8. Hybrid protein-inorganic nanoparticles for drug delivery 9. Silica based hybrid systems for drug delivery 10. Dendrimer nanohybrid systems for drug delivery 11. Bioactive hybrid nanowires for drug delivery 12. Hybrid carbon-based materials for drug delivery 13. Quantum dots hybrid systems for drug delivery 14. Strengths, limitations and regulatory aspects of hybrid drug delivery systems 15. Recent advances and future prospective of hybrid drug delivery systems
1. Nanostructures and their associated challenges for drug delivery 2. Characterization techniques of hybrid drug delivery systems 3. Hybrid drug nanocrystals for drug delivery 4. Hybrid nanogel systems for drug delivery 5. Polymer-lipid hybrid nanostructures for drug delivery 6. Hybrid chitosan-based drug delivery systems for drug delivery 7. Hybrid polymer-metal composites for drug delivery 8. Hybrid protein-inorganic nanoparticles for drug delivery 9. Silica based hybrid systems for drug delivery 10. Dendrimer nanohybrid systems for drug delivery 11. Bioactive hybrid nanowires for drug delivery 12. Hybrid carbon-based materials for drug delivery 13. Quantum dots hybrid systems for drug delivery 14. Strengths, limitations and regulatory aspects of hybrid drug delivery systems 15. Recent advances and future prospective of hybrid drug delivery systems
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309